<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

Past speakers


Innovation across biotech, medtech and healthtech

Marc Appel, CEO, Orange Grove Bio

Marc Appel

CEO
Orange Grove Bio
Gwilym Attwell, Principal, Fish & Richardson

Gwilym Attwell

Principal
Fish & Richardson
Elizabeth Bailey, Managing Director, Rhia Ventures 300x

Elizabeth Bailey

Managing Director
RH Capital
Michael Bailey, President & CEO, AVEO Oncology

Michael Bailey

President & CEO
AVEO Oncology
Robert Barberi, SVP Director - Cyber Security & Professional Risk, Willis Towers Watson

Rob Barberi

Senior Vice President, Director - Cyber Security & Professional Risk
WTW
Caroline Barelle, CEO, Elasmogen

Caroline Barelle

CEO
Elasmogen
Bob Bargenquast, Head of U.S. Market Access Strategy & Reimbursement, Zeiss

Bob Bargenquast

Head of U.S. Market Access Strategy & Reimbursement
Zeiss
Robert Barrow, CEO, MindMed

Robert Barrow

CEO
MindMed
Anna Barry, Chief Legal Officer & Head of Corporate Strategy, Korro Bio

Anna Barry

Chief Operating Officer
Korro Bio
Gregory Benning, Managing Director, Group Head - Investment Banking, Back Bay Life Science

Gregory Benning

Managing Director, Group Head - Investment Banking
Back Bay Life Science Advisors
Sharon Benzeno, CBO, Adaptive Biotech 300x

Sharon Benzeno

Chief Commercial Officer
Adaptive Biotechnologies
Maggie Berkeley, Partner, Risk Advisory, RSM

Maggie Berkeley

Partner, Risk Advisory
RSM
Saurabh Bhasin, Vice President of M&A, Fresenius Kabi

Saurabh Bhasin

Vice President of M&A
Fresenius Kabi
Jens Bitsch-Norhave, VP Early Innovation Partnering, East North America, J&J Innovation

Jens Bitsch-Norhave

VP, Transactions & Innovation Partnering, East North America
J&J Innovation
Simon Blanc, Medical Director, IntegraConnect

Simon Blanc

Medical Director
IntegraConnect
Gaye Bok, Partner, AI and Digital Innovation Fund, Mass General Brigham

Gaye Bok

Partner, AI and Digital Innovation Fund
Mass General Brigham
Travis Bond, Chief Executive Officer, Altoida

Travis Bond

Chief Executive Officer
Altoida
Joseph Boncore, CEO, MassBio; Former Massachusetts State Senator (2016-2021)

Joseph Boncore

CEO, MassBio
Former Massachusetts State Senator (2016-2021)
Melissa Bradford-Klug, Chief Business Officer, Rarestone Group

Melissa Bradford-Klug

Chief Operating Officer
Akari Therapeutics
Rachel Braun Scherl, Co-Founder & Managing Partner, SPARK Solutions for Growth

Rachel Braun Scherl

Business Builder, Marketing Strategist and Vagipreneur®
SPARK Solutions for Growth
Christine Brennan, Partner, MRL Ventures Fund LLC

Christine Brennan

Managing Partner
Vertex Ventures HC
Amanda Briscoe, SVP, Business Development, Veranex Solutions

Amanda Briscoe

SVP, Business Development
Veranex Solutions
Matthew Cardinal, VP Strategy & Program Leadership, Halloran Consulting Group

Matthew Cardinal

VP Strategy & Program Leadership
Halloran Consulting Group
Christopher Cleary, VP Corporate Development, Medtronic

Christopher Cleary

VP Corporate Development
Medtronic
Stacy Cline Amin, Partner, Morrison Foerster; Former Chief Counsel of the FDA & Deputy General Counsel of the Department of Health and Human Services (HS)

Stacy Cline Amin

Partner, Morrison Foerster
Former Chief Counsel of the FDA & Deputy General Counsel of the Department of Health and Human Services (HS)
Michael Cohen, Partner, Brown Rudnick

Michael Cohen

Partner
Brown Rudnick
Alan Collis, Vice President, Integrated Drug Discovery Services, Syngene International

Alan Collis

Vice President, Integrated Drug Discovery Services
Syngene International Ltd
Andrea Conner, Vice President Programs Strategy, Springboard Enterprises

Andrea Conner

Vice President Programs Strategy
Springboard Enterprises
Carrie Cook, Chief Business Officer, Cerevance

Carrie Cook

Chief Business Officer
Cerevance
Travis Coy, Vice President, Transaction and M&A, Corporate Business Development, Eli Lilly

Travis Coy

Vice President, Transaction and M&A, Corporate Business Development
Eli Lilly
Sharon Cunningham, CEO, Shorla Pharma

Sharon Cunningham

CEO
Shorla Oncology
Stephen Curtis, Managing Director, MPM Capital

Stephen Curtis

Managing Director
MPM Capital
Adam Dakin, Managing Director, Healthtech, Dreamit Ventures

Adam Dakin

Partner, HealthTech
Dreamit Ventures
Chad Davis, Partner, Dechert

Chad Davis

Partner
Dechert
Peter Day, Co-Head of Healthcare Investment Banking, Piper Sandler

Peter Day

Co-Head of Healthcare Investment Banking
Piper Sandler
Cris de Luca, Global Head, Digital Investments, Sanofi Ventures

Cris de Luca

Global Head, Digital Investments
Sanofi Ventures
Gati Dharani, Director, Innovation Lab, Pfizer

Gati Dharani

Director, Innovation Lab
Pfizer
Shailja Dixit, CEO, Curio Digital Therapeutics

Shailja Dixit

CEO
Curio Digital Therapeutics
Douglas Fambrough, CEO, Dicerna Pharmaceuticals

Douglas Fambrough

CEO
Dicerna Pharmaceuticals
Rachel Ford Hutman, Founder and CEO Hutman Media 300x

Rachel Ford Hutman

CEO
Ford Hutman Media
Jonathan Fox, Managing Director, Deloitte

Jonathan Fox

Managing Director
Deloitte
Sheila Frame, President of the Americas, Amyrt

Sheila Frame

President of the Americas
Amryt Pharma
Jennifer Fried, CEO & Co-Founder, Explorer Surgical

Jennifer Fried

CEO & Co-Founder
Explorer Surgical
James Gallagher, Life Sciences Regulatory Partner, Mason Hayes & Curran LLP

James Gallagher

Life Sciences Regulatory Partner
Mason Hayes & Curran LLP
Shaan Gandhi, Director, Northpond Ventures

Shaan Gandhi

Director
Northpond Ventures
Robert Garber, Partner, 7WireVentures

Robert Garber

Partner
7wireVentures
Katy Gardner, Partner, Brown Rudnick

Katy Gardner

Partner
Brown Rudnick
Leslie Gautam, Executive Director, Torreya

Leslie Gautam

Executive Director
Torreya
Jonathan Gertler, Managing Partner & CEO, Back Bay Life Science Advisors 300x

Jonathan Gertler

Managing Parter & CEO
Back Bay Life Science Advisors BioVentures Medtech Funds
Doug Giordano, Managing Director, Perceptive Advisors

Doug Giordano

Managing Director
Perceptive Advisors
Townsend Goddard, Senior VP of Global Business Development, Olympus

Townsend Goddard

Senior VP of Global Business Development
Olympus
Jernej Godec, Principal, Atlas Ventures

Jernej Godec

Principal
Atlas Ventures
Clifford Goldsmith, US Health and Life Sciences Chief Medical Officer, Microsoft

Clifford Goldsmith

US Health and Life Sciences Chief Medical Officer
Microsoft
Michael Greeley, General Partner, Flare Capital Partners

Michael Greeley

General Partner
Flare Capital Partners
Luba Greenwood, CEO, Kojin Therapeutics

Luba Greenwood

Managing Director, Dana-Faber Ventures Fund
CEO, Kojin
Stephen Hahn, CEO & Partner, Flagship Pioneering

Stephen Hahn

CEO & Partner, Flagship Pioneering
CEO, Harbinger Health; Former US FDA Commissioner (2019-2021)
Giles Hamilton, CEO, ODx Innovations

Giles Hamilton

CEO
ODx Innovations
Deanna Harshbarger, VP Product, Cala Health

Deanna Harshbarger

VP Product
Cala Health
Matthew Hawryluk, EVP & Chief Business Officer, Gritstone bio

Matthew Hawryluk

EVP & Chief Business Officer
Gritstone bio
Zach Henderson, Chief Commercial Officer, Glooko

Zach Henderson

CCO
Glooko
Peter Henstock, Machine Learning & AI Technical Lead, Pfizer

Peter Henstock

Machine Learning & AI Technical Lead
Pfizer
William Hicks, Co-Chair, Securities & Capital Markets Practice, Mintz

William Hicks

Co-chair Securities & Capital Markets Group
Mintz
Albert Hsia, Executive Director, Business Development, Merck

Albert Hsia

Executive Director, Business Development
Merck
Lori Hu, Managing Director, Vertex Ventures

Lori Hu

Managing Director
Vertex Ventures
Thomas Hummel, Head of Strategy & Innovation, Siemens Healthineers

Thomas Hummel

Head of Strategy & Innovation
Siemens Healthineers
Christina Isacson, Partner, Lightstone Ventures

Christina Isacson

Partner
Lightstone Ventures
Andrea Jackson, Director, Northpond Ventures 300x

Andrea Jackson

Director
Northpond Ventures
Gabriel Jones, CEO & Co-Founder, Proprio

Gabriel Jones

CEO & Co-Founder
Proprio
Sree Kant, Founder & CEO, Bakx Therapeutics

Sree Kant

Founder & CEO
Bakx Therapeutics
Matthew Karlyn, Partner, Morrison & Foerster LLP

Matthew Karlyn

Partner
Morrison & Foerster LLP
Maha Katabi, General Partner, Sofinnova Investments

Maha Katabi

General Partner
Sofinnova Investments
Jeff Katz, Director, Strategic Finance, RSM

Jeff Katz

Director, Strategic Finance
RSM
Martin Kelleher, Corporate Partner and Head of the Life Sciences Team, Mason Hayes & Curran

Martin Kelleher

Corporate Partner and Head of the Life Sciences Team
Mason Hayes & Curran
Oliver Keown, Managing Director, Intuitive Ventures

Oliver Keown

Managing Director
Intuitive Ventures
Minji Kim, General Manager, AffaMed Digital

Minji Kim

General Manager
AffaMed Digital
Sahil Kirpekar, Head of Business Development, Otsuka

Sahil Kirpekar

Head of Business Development
Otsuka
Ned Kitfield, Chief Commercial Officer, Ambit

Ned Kitfield

Chief Commercial Officer
Ambit
Nina Kjellson, General Partner, Canaan

Nina Kjellson

General Partner
Canaan
Anjali Kumar, External Innovation Search and Evaluation, Eastern United States, Johnson & Johnson Innovation

Anjali Kumar

Sr. Director of External Innovation Search and Evaluation
Johnson & Johnson
Adam Landman, VP, Chief Information and Digital Innovation Officer, Harvard University

Adam Landman

VP, Chief Information and Digital Innovation Officer
Harvard University
Ruta Laukien, Managing Partner, Graybella Capital

Ruta Laukien

Managing Partner
Graybella Capital
Robb Lawrence, SVP, Commercial Strategy Solutions, Premier Consulting

Robb Lawrence

SVP, Commercial Strategy Solutions
Premier Consulting
Andy Lee, Chief Operating Officer, Vincere Biosciences

Andy Lee

Chief Operating Officer
Vincere Biosciences
Jin Lee, Director of Digital Health, Rx+Global, Astellas Pharma US

Jin Lee

Director of Digital Health, Rx+ Business Accelerator
Astellas Pharma Inc
Kathy Lee-Sepsick, President & Chief Executive Officer, Femasys

Kathy Lee-Sepsick

President & Chief Executive Officer
Femasys
Christopher Leo, Managing Director, Back Bay Life Science Advisors

Christopher Leo

Managing Director
Back Bay Life Science Advisors
Lizabeth Leveille, Head, Boston & Europe BD&L, Merck

Lizabeth Leveille

Head, Boston & Europe BD&L
Merck
Francois Lilienthal, Chief Commercial Officer, MindMed

Francois Lilienthal

Chief Commercial Officer
MindMed
Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund

Debbie Lin

Executive In Residence, DigitalDx
Former Pharma Corporate Venture Investment Executive
Ben Linville-Engler, Chief Investment Strategist and Program Executive, Massachusetts Technology Collaborative

Ben Linville-Engler

Chief Investment Strategist & Program Executive
Massachusetts Technology Collaborative
Sarah Liu, Chief Commercial Officer, 9 Meters Biopharma

Sarah Liu

Chief Commercial Officer
9 Meters Biopharma
Brad Loncar, Chief Executive Officer, Loncar Investments

Brad Loncar

Chief Executive Officer
Loncar Investments
Michael Machin, Senior Vice President, M&A Group, WTW

Michael Machin

Senior Vice President, M&A Group
WTW
Stuart Mackey, Global Head, BD, Daiichi Sankyo

Stuart Mackey

Global Head, BD
Daiichi Sankyo
Ivana Magovcevic-Liebisch, CEO, Vigil Neuroscience

Ivana Magovcevic-Liebisch

CEO
Vigil Neuroscience
Ankit Mahadevia, Founder and CEO, Spero Therapeutics

Ankit Mahadevia

Founder and CEO
Spero Therapeutics
Michael Maline, Member, Mintz

Michael Maline

Member
Mintz
Konstantina Manjoros-Katcheves, SVP Business Development, Bristol-Myers Squibb

Konstantina Katcheves

SVP, Business Development, Innovative Technologies & Geographic Search
Bristol Myers Squibb
Lorraine Marchand, General Manager, Life Sciences, Watson Health, IBM

Lorraine Marchand

General Manager, Life Sciences, Watson Health
IBM
Tom Marron, Vice President – Venture Science, Eli Lilly

Tom Marron

Vice President – Venture Science
Eli Lilly
Christopher Martin, Principal, RSM

Christopher Martin

Principal
RSM
Sean McClain, Founder & CEO, Absci

Sean McClain

Founder & CEO
Absci
Jason McEwan, Senior Director, Regulatory Affairs, Premier Consulting

Jason McEwan

Senior Director, Regulatory Affairs
Premier Consulting
Shari Medendorp, President, Premier Consulting

Shari Medendorp

President
Premier Consulting
Christopher Mellen, Chief Information Security Officer, Ginkgo Bioworks

Christopher Mellen

Chief Information Security Officer
Ginkgo Bioworks
Cindy Mesaros, Head of Brand & People, Foresite Capital

Cindy Mesaros

Head of Brand & People
Foresite Capital
Elizabeth Mily, EVP BD, Bristol Myers Squibb 300x

Elizabeth Mily

Executive Vice President, Strategy and Business Development
Bristol-Myers Squibb
Will Morris, Healthcare Life Sciences Lead, Google

Will Morris

Healthcare Life Sciences Lead
Google
David Nace, Chief Medical Officer, Innovaccer

David Nace

Chief Medical Officer
Innovaccer
Ivana Naeymi-Rad, Chief Operating Officer, Intelligent Medical Objects

Ivana Naeymi-Rad

Chief Operating Officer
Intelligent Medical Objects
Ronjon Nag, Founder, R42 Group

Ronjon Nag

Founder
R42 Group
Amir Naiberg, Associate Vice Chancellor, Chief Executive Officer and President, UCLA TDG

Amir Naiberg

Associate Vice Chancellor, Chief Executive Officer and President
UCLA TDG
Huw Nash, COO and CBO, Stoke Therapeutics

Huw Nash

COO and CBO
Stoke Therapeutics
Imran Nasrullah, Vice President & Head, Open Innovation Center North America, Bayer

Imran Nasrullah

Vice President & Head, Open Innovation Center North America
Bayer
Steven Neier, Principal, Binney Street Capital, Dana Farber Ventures Fund

Steven Neier

Principal, Binney Street Capital
Dana Farber Ventures Fund
Etienne Nichols, Medical Device Guru & Community Manager, Greenlight Guru

Etienne Nichols

Medical Device Guru & Community Manager
Greenlight Guru
Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive

Julian Nikolchev

Senior VP Corporate Development & Strategy
Intuitive
Shani Noel, Director, Market Access & Managed Care, Respiratory Health, Baxter

Shani Noel

Director, Market Access & Managed Care, Respiratory Health
Baxter
Samantha OConnor, Head, Business and Operations, Emerging Sciences & Innovation (ES&I), Pfizer

Samantha O'Connor

Head, Business and Operations, Emerging Sciences & Innovation (ES&I)
Pfizer
Chris ODonnell, Executive Director of WRDM and Partner at Pfizer Ventures, Pfizer

Chris O'Donnell

Vice President, WRDM and Partner at Pfizer Ventures
Pfizer
Delphine O’Rourke, Partner, Goodwin Procter

Delphine O’Rourke

Women’s Health & Wellness/Healthcare Partner
Goodwin Procter
Jonathan Pappas, Vice President, LifeSci Communications

Jonathan Pappas

Vice President
LifeSci Communications
Jennifer Petter, Founder & Chief Innovation Officer, Arrakis Therapeutics

Jennifer Petter

Founder & Chief Innovation Officer
Arrakis Therapeutics
Enrico Picozza, Partner, HLM Venture Partners

Enrico Picozza

Partner
HLM Venture Partners
Alex Philippidis, Senior Business Editor, Genetic Engineering News

Alex Philippidis

Senior Business Editor
Genetic Engineering News
Scott Platshon, Partner, EcoR1 Capital

Scott Platshon

Partner
EcoR1 Capital
Stephanie Richards, Partner, Goodwin Procter

Stephanie Richards

Partner
Goodwin Procter
Paul Roben, Associate Vice Chancellor for Innovation & Commercialisation, UC San Diego

Paul Roben

Associate Vice Chancellor for Innovation & Commercialisation
UC San Diego
Christine Roche, Digital Health Innovation Lead, Amgen

Christine Roche

Digital Health Innovation Lead
Amgen
Matthew Roden, Executive Partner, MPM Capital and Chief Executive Officer, AKTIS Oncology

Matthew Roden

Executive Partner, MPM Capital
Chief Executive Officer, AKTIS Oncology
Sean Ryan, Partner, McKinsey & Company

Sean Ryan

Partner
McKinsey
Neil Sahota, United Nations Artificial Intelligence Advisor

Neil Sahota

Artificial Intelligence Advisor
United Nations
Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD

Antonio Sanchez-Cordero

VP Business Development (M&A) Peripheral Intervention
BD
Matthew Savary, Innovation Fund & New Ventures Principal – Medtech, UCLA Technology Development Group

Matthew Savary

Innovation Fund & New Ventures Principal – Medtech
UCLA Technology Development Group
Adam Schoen, Partner, Brown Rudnick

Adam Schoen

Partner
Brown Rudnick
Jeffrey Schwartz, Managing Director, Bain Capital

Jeffrey Schwartz

Managing Director
Bain Capital
Jerrold Shapiro, President, Floelle Inc.

Jerrold Shapiro

President
Floelle Inc.
Maria Shepherd, President, Medi-Vantage

Maria Shepherd

President
Medi-Vantage
Jiye Shi, Associate VP, Head of Computational Design and Automation Platforms, Eli Lilly

Jiye Shi

Associate VP, Head of Computational Design and Automation Platforms
Eli Lilly
Will Spagnoli, Chief Technology Officer, Phronesis Artificial

Will Spagnoli

Chief Technology Officer
Phronesis Artificial Intelligence
KC Stone, Head of Healthcare, BTIG

KC Stone

Head of Healthcare Investment Banking
BTIG
Heather Sugrue, VP - Business Development Discovery Services, Syngene International Ltd

Heather Sugrue

Vice President, Integrated Drug Discovery Services
Syngene International Ltd
Alan Tamarelli, Partner, Cooley LLP

Alan Tamarelli

Partner
Cooley LLP
Nilay Thakar, Principal, ARCH Venture Partners

Nilay Thakar

Principal
ARCH Venture Partners
Tamar Thompson, Head, Corporate Affairs, Alexion, AstraZeneca Rare Disease

Tamar Thompson

Head, Corporate Affairs
Alexion, AstraZeneca Rare Disease
Chuck Triano, Chief Financial Officer, Xalud Therapeutics

Chuck Triano

Chief Financial Officer
Xalud Therapeutics
Ramani Varanasi, President & CEO, X-Biotix Therapeutics

Ramani Varanasi

President & CEO
X-Biotix Therapeutics
Dominique Verhelle, CEO and Co-Founder, NextRNA Therapeutics

Dominique Verhelle

CEO and Co-Founder
NextRNA Therapeutics
Lea Von Bidder, CEO, Ava

Lea Von Bidder

CEO
Ava
Amy Waldron, Global Leader, Healthcare & Life Sciences Solutions, Google Cloud - Health Plans, Google

Amy Waldron

Global Leader, Healthcare & Life Sciences Solutions, Google Cloud - Health Plans
Google
Rowan Walrath, Life sciences reporter, Boston Business Journal

Rowan Walrath

Life Sciences Reporter
Boston Business Journal
Sally Wang Liang, EIR, Orange Grove Bio

Sally Wang Liang

Venture Partner
Viva Bioinnovator
Chris Wasden, Head, Happify Health

Chris Wasden

Chief Strategy Officer
Happify
Anita Watkins, Managing Director, Rex Health Ventures

Anita Watkins

Managing Director
Rex Health Ventures
John Westwood, Partner & Global Life Sciences Business Leader, Oliver Wyman

John Westwood

Partner & Global Life Sciences Business Leader
Oliver Wyman
Richard Wilmot, Head, Philips Health Tech Ventures

Richard Wilmot

Head
Philips Health Tech Ventures
James Williams, Global Head and Executive Director of Digital Health Research, Biogen

James Williams

Global Head and Executive Director of Digital Health Research
Biogen
Claire Woodthorpe, VP, Europe & COO, Lightpoint Medical

Claire Woodthorpe

VP Europe, Chief Operating Officer
Light Point Medical
Peter Wright, Partner, McKinsey & Company

Peter Wright

Partner
McKinsey
Julianne Zimmerman, Managing Director, Reinventure Capital

Julianne Zimmerman

Managing Director
Reinventure Capital
Amir Zur, Head of R&D, Digital Health, Takeda

Amir Zur

Head of R&D, Digital Health
Takeda
DOWNLOAD BROCHURE